BlinkLab is trading 8.66% up at A$0.69 on September 30, 2026, with no confirmed company-specific catalyst identified.
- Volume exceeded the daily average by 138.11%.
- Positive European ADHD study results, reporting 82% sensitivity and 83% specificity, were announced in August and do not establish the cause of this session’s gain.
- The provided healthcare-sector context was negative and does not explain the rise.